These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

169 related articles for article (PubMed ID: 33450087)

  • 1. Emerging benefits and drawbacks of α
    Lankadeva YR; Shehabi Y; Deane AM; Plummer MP; Bellomo R; May CN
    Br J Pharmacol; 2021 Mar; 178(6):1407-1425. PubMed ID: 33450087
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Perioperative use of alpha2-adrenoceptor agonists and the cardiac patient.
    Aantaa R; Jalonen J
    Eur J Anaesthesiol; 2006 May; 23(5):361-72. PubMed ID: 16507202
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The effect of dexmedetomidine and clonidine on the inflammatory response in critical illness: a systematic review of animal and human studies.
    Flanders CA; Rocke AS; Edwardson SA; Baillie JK; Walsh TS
    Crit Care; 2019 Dec; 23(1):402. PubMed ID: 31829277
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Efficacy of α2-Agonists for Sedation in Pediatric Critical Care: A Systematic Review.
    Hayden JC; Breatnach C; Doherty DR; Healy M; Howlett MM; Gallagher PJ; Cousins G
    Pediatr Crit Care Med; 2016 Feb; 17(2):e66-75. PubMed ID: 26704469
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Alpha-2 agonists for sedation of mechanically ventilated adults in intensive care units: a systematic review.
    Cruickshank M; Henderson L; MacLennan G; Fraser C; Campbell M; Blackwood B; Gordon A; Brazzelli M
    Health Technol Assess; 2016 Mar; 20(25):v-xx, 1-117. PubMed ID: 27035758
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Perioperative adverse events attributed to α2-adrenoceptor agonists in patients not at risk of cardiovascular events: systematic review and meta-analysis.
    Demiri M; Antunes T; Fletcher D; Martinez V
    Br J Anaesth; 2019 Dec; 123(6):795-807. PubMed ID: 31623842
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Use of Dexmedetomidine in Cardiothoracic and Vascular Anesthesia.
    Gallego-Ligorit L; Vives M; Vallés-Torres J; Sanjuán-Villarreal TA; Pajares A; Iglesias M
    J Cardiothorac Vasc Anesth; 2018 Jun; 32(3):1426-1438. PubMed ID: 29325842
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Dexmedetomidine: new insights.
    Mantz J; Josserand J; Hamada S
    Eur J Anaesthesiol; 2011 Jan; 28(1):3-6. PubMed ID: 20881501
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Effects of alpha2-adrenoceptor agonists on tetrodotoxin-resistant Na+ channels in rat dorsal root ganglion neurons.
    Oda A; Iida H; Tanahashi S; Osawa Y; Yamaguchi S; Dohi S
    Eur J Anaesthesiol; 2007 Nov; 24(11):934-41. PubMed ID: 17568475
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Effectiveness of α
    Hayden JC; Dawkins I; Breatnach C; Leacy FP; Foxton J; Healy M; Cousins G; Gallagher PJ; Doherty DR
    BMJ Open; 2017 May; 7(5):e013858. PubMed ID: 28566361
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Alpha-2 adrenoreceptor agonists for the intensive care physician].
    Gavino L; Willaredt M; Chiche JD; Ben-Hamouda N
    Rev Med Suisse; 2023 May; 19(825):872-877. PubMed ID: 37139883
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Alpha-2 adrenoceptor agonists and sepsis: improved survival?
    Quintin L
    Crit Care; 2010; 14(4):429; author reply 429. PubMed ID: 20727233
    [No Abstract]   [Full Text] [Related]  

  • 13. Dexmedetomidine inhibits astrocyte pyroptosis and subsequently protects the brain in in vitro and in vivo models of sepsis.
    Sun YB; Zhao H; Mu DL; Zhang W; Cui J; Wu L; Alam A; Wang DX; Ma D
    Cell Death Dis; 2019 Feb; 10(3):167. PubMed ID: 30778043
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Desensitization to the behavioral effects of alpha 2-adrenergic agonists in rats.
    Hayashi Y; Guo TZ; Maze M
    Anesthesiology; 1995 Apr; 82(4):954-62. PubMed ID: 7717568
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Synergistic interactions between two alpha(2)-adrenoceptor agonists, dexmedetomidine and ST-91, in two substrains of Sprague-Dawley rats.
    Graham BA; Hammond DL; Proudfit HK
    Pain; 2000 Mar; 85(1-2):135-43. PubMed ID: 10692612
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Effects of alpha(2)-adrenoceptor agonists on perinatal excitotoxic brain injury: comparison of clonidine and dexmedetomidine.
    Laudenbach V; Mantz J; Lagercrantz H; Desmonts JM; Evrard P; Gressens P
    Anesthesiology; 2002 Jan; 96(1):134-41. PubMed ID: 11753013
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Evaluating the use of dexmedetomidine for the reduction of delirium: An integrative review.
    Pavone KJ; Cacchione PZ; Polomano RC; Winner L; Compton P
    Heart Lung; 2018 Nov; 47(6):591-601. PubMed ID: 30266265
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Ultrasonic vocalization production of preweanling rats: effects of central and peripheral administration of alpha2-adrenoceptor agonists.
    Krall CM; Andicochea CT; McDougall SA
    Eur J Pharmacol; 2005 Jul; 517(3):200-7. PubMed ID: 15985263
    [TBL] [Abstract][Full Text] [Related]  

  • 19. alpha2-Adrenergic agonists protect against radiocontrast-induced nephropathy in mice.
    Billings FT; Chen SW; Kim M; Park SW; Song JH; Wang S; Herman J; D'Agati V; Lee HT
    Am J Physiol Renal Physiol; 2008 Sep; 295(3):F741-8. PubMed ID: 18579700
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Depression of NMDA receptor-mediated synaptic transmission by four alpha2 adrenoceptor agonists on the in vitro rat spinal cord preparation.
    Faber ES; Chambers JP; Evans RH
    Br J Pharmacol; 1998 Jun; 124(3):507-12. PubMed ID: 9647475
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.